Quarterly report pursuant to Section 13 or 15(d)

Supplemental Disclosure for Statements of Cash Flows (Details)

v3.2.0.727
Supplemental Disclosure for Statements of Cash Flows (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2015
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
May. 15, 2015
Dec. 31, 2014
Class of Stock [Line Items]              
Cash paid during the period for interest       $ 2,000,000 $ 1,400,000    
Derivative liabilities   $ 63,000   63,000     $ 0
Deemed dividend on beneficial conversion feature of MT Preferred Stock   0 $ 0 (46,000) 0    
Convertible Preferred Stock              
Class of Stock [Line Items]              
Deemed dividend on beneficial conversion feature of MT Preferred Stock $ 46,000            
Macrophage Therapeutics | Convertible Preferred Stock              
Class of Stock [Line Items]              
Deemed dividend on beneficial conversion feature of MT Preferred Stock $ 46,000            
Capital Royalty Group              
Class of Stock [Line Items]              
End-of-term fee   $ 1,000,000   $ 1,000,000   $ 1,000,000  
Oxford Finance, LLC              
Class of Stock [Line Items]              
End-of-term fee     $ 2,400,000   $ 2,400,000 $ 2,400,000